Pharmacology

Antiplatelet

Rivaroxaban reduces in-stent thrombosis in patients with acute coronary syndromes

Original title: Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2...

solaci - 23 August, 2013

Learn More

Antiplatelet

Transradial access plus bivalirudin, the best combination to reduce bleeding

Original title: Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous...

solaci - 15 August, 2013

Learn More

Interventional Cardiologists

Riociguat, a new drug for pulmonary arterial hypertension

Título original: Riociguat for the Treatment of Pulmonary Arterial Hypertension. Referencia: Hossein-Ardeschir Ghofrani et al. N Engl J Med 2013;369:330-40. Many...

solaci - 31 July, 2013

Learn More

Acute coronary syndromes

Ticagrelor similar to clopidogrel in terms of coronary flow and myocardial perfusion

Título original: Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). Referencia: Vijay Kunadian et al. J Am...

solaci - 19 July, 2013

Learn More

Chronic Ischemic cardiopathy

High doses of statins may reduce the lipid content in severe injury

Original title: Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy. The YELLOW Trial (Reduction...

solaci - 15 July, 2013

Learn More

Acute coronary syndromes

Monoclonal antibodies to decrease peri-procedural myocardial damage

Original title: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation...

solaci - 3 July, 2013

Learn More

Antiplatelet

Rational use of bivalirudin, less bleeding and less costs using risk score

Original title: Pre-Procedural Estimate of Individualized Bleeding Risk Impacts Physicians’ Utilization of Bivalirudin During Percutaneous Coronary Intervention. Reference: Seshu C....

solaci - 2 July, 2013

Learn More

Interventional Cardiologists

High doses of Rosuvastatin in acute coronary syndromes

Original title: Rosuvastatin calcium in acute coronary sydromes Reference: Aggarwal, R. et al, Expert Opinion on Pharmacotherapy , Volume 14,...

solaci - 19 June, 2013

Learn More

Rivaroxaban reduces in-stent thrombosis in patients with acute coronary syndromes

Transradial access plus bivalirudin, the best combination to reduce bleeding

Riociguat, a new drug for pulmonary arterial hypertension

Ticagrelor similar to clopidogrel in terms of coronary flow and myocardial perfusion

High doses of statins may reduce the lipid content in severe injury

Monoclonal antibodies to decrease peri-procedural myocardial damage

Rational use of bivalirudin, less bleeding and less costs using risk score

High doses of Rosuvastatin in acute coronary syndromes

Last News

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Institutional News

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Access